[Weekly dosage of docetaxel combined with cisplatin and 5-fluorouracil in the treatment of advanced gastric cancer].
To observe the effects and toxicity of docetaxel given once weekly combined with cisplatin and 5-fluororacil in the treatment of advanced gastric cancer (AGC). Thirty-one patients with AGC were given docetaxel at 35 mg/m square by intravenous infusion completed in 1 h on the 1st, 8th and 15th days. Cisplatin was given at 20 mg/m square for 4 h between the 2nd and 6th days, during which time 5-fluororacil was also given at 750 mg/m square for 24 h. One treatment cycle lasted for 28 days and 2 consecutive cycles were administered. In the 31 patients available for therapeutic effect evaluation, the overall effective rate was 48.4%. The effective rate in patients without previous treatments was 64.7% (CR in 2 cases), and 28.6% in the retreated patients. The median TTP, median survival time and one-year survival rate were 6 months, 11 months and 41.9%, respectively. The main toxic reactions of the combined treatment were myelosuppression, gastrointestinal tract reaction and alopecia of mostly grade 1 or 2. Weekly dosage of docetaxel combined with cisplatin and 5-fluororacil is an effective regimen for AGC with only mild toxic reactions and good patient tolerance.